清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

No Difference Unicompartmental Knee Arthroplasty for Medial Knee Osteoarthritis With or Without Anterior Cruciate Ligament Deficiency: A Systematic Review and Meta-analysis

医学 单室膝关节置换术 骨关节炎 前交叉韧带 置信区间 牛津膝关节得分 关节置换术 荟萃分析 物理疗法 外科 内科学 病理 替代医学
作者
Genfa Du,Hongtao Qiu,Jianzong Zhu,Hongbo Wang,Qinghua Xiao,Zhen Zhang,Xiaosheng Lin,Guangming Zheng
出处
期刊:Journal of Arthroplasty [Elsevier BV]
卷期号:38 (3): 586-593.e1 被引量:20
标识
DOI:10.1016/j.arth.2022.10.018
摘要

A functional intact anterior cruciate ligament (ACLI) is considered to be a prerequisite for unicompartmental knee arthroplasty (UKA). However, UKA has been shown to have good clinical efficacy in ACL-deficient (ACLD) knees at 3 to 10 years follow-up. Therefore, the role of ACLD in UKA remains controversial, and more evidence is needed to clarify the role of ACLD in UKA.PubMed, the Web of Science, EMBASE, and Cochrane Central were queried for articles comparing the results of the ACLD and ACLI groups after UKA. Outcomes of interest included the Tegner Activity Scale, the Oxford Knee Score (OKS), postoperative slope of the implant (PSI), the Knee Injury and Osteoarthritis Outcomes Score (KOOS), the Lysholm score, and revision rate. There were eight studies included. The mean age was 66 years (range 49 to 87 year old) and the mean follow-up time was 6.9 years (range 1.3 to 16.6 years). There was baseline comparability regarding mean age, duration of follow-up, and body mass index (P > .5) between the ACLD and ACLI groups.The ACLD and ACLI groups had improved postoperative functional indicators, and that postoperative revision rate (mean difference [MD], 1.24; 95% confidence interval [CI], 0.75 to 2.04; P = .4), Tegner score (MD, -0.1; 95% CI, -0.26 to 0.05; P = .19), and Lysholm score (95% CI, -2.46 to 7.32; P = .33) were similar between the groups, with no significant differences; however, the ACLD groups had significantly better KOOS Activities of Daily Living scores, with a significant difference (MD, 4.53; 95% CI, 1.75 to 7.3; P = .001). Also, there were no significant differences between two groups in the PSI, OKS, KOOS.ACL deficiency is not always a contraindication for UKA. With correct patient selection, UKA could be considered for medial knee osteoarthritis with ACL deficiency without antero-posterior instability, especially these people over 60 years of age.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsmj23完成签到 ,获得积分0
4秒前
fabius0351完成签到 ,获得积分10
9秒前
10秒前
everyone_woo发布了新的文献求助10
14秒前
Jasper应助everyone_woo采纳,获得10
25秒前
loii举报解语花031求助涉嫌违规
37秒前
大医仁心完成签到 ,获得积分10
44秒前
50秒前
50秒前
everyone_woo发布了新的文献求助10
55秒前
56秒前
田様应助everyone_woo采纳,获得10
1分钟前
1分钟前
1分钟前
AA完成签到 ,获得积分10
1分钟前
1分钟前
Sylvia完成签到 ,获得积分10
1分钟前
Lucas应助袁青寒采纳,获得10
1分钟前
1分钟前
久晓完成签到 ,获得积分10
1分钟前
everyone_woo发布了新的文献求助10
1分钟前
科研通AI6.1应助everyone_woo采纳,获得10
1分钟前
喜悦的小土豆完成签到 ,获得积分10
2分钟前
无花果应助袁青寒采纳,获得10
2分钟前
Criminology34应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
Criminology34应助科研通管家采纳,获得20
2分钟前
2分钟前
nick完成签到,获得积分10
2分钟前
Kevin发布了新的文献求助10
2分钟前
Zulyadaini完成签到,获得积分10
2分钟前
情怀应助袁青寒采纳,获得10
2分钟前
SciGPT应助向前采纳,获得10
2分钟前
两个榴莲完成签到,获得积分0
3分钟前
3分钟前
向前发布了新的文献求助10
3分钟前
3分钟前
袁青寒发布了新的文献求助10
3分钟前
袁青寒发布了新的文献求助10
3分钟前
科研通AI2S应助没心没肺采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362214
求助须知:如何正确求助?哪些是违规求助? 8175805
关于积分的说明 17224164
捐赠科研通 5416914
什么是DOI,文献DOI怎么找? 2866596
邀请新用户注册赠送积分活动 1843775
关于科研通互助平台的介绍 1691531